Introduction
When naive B cells recognize T cell-dependent antigens via the BCR and receive help from T h cells, they become activated and undergo proliferation and differentiation. Some cells migrate to the extrafollicular region and differentiate into short-lived plasma cells (PCs) (1) . These cells secrete IgM or IgG antibodies, which are in germline configuration and have relatively low affinity to antigens. Other cells migrate into follicles and form germinal centers (GCs) (2) (3) (4) where somatic hypermutation (SHM) and class-switch recombination (CSR) are considered to take place. Both processes are dependent on activation-induced cytidine deaminase (AID) (5) .
In GCs, the affinity of BCRs is changed through SHM and B cells are screened by antigens on follicular dendritic cells; B cells that obtain BCRs of higher affinity to antigens are selected and leave GCs, while B cells that acquire self-reactivity or lose affinity to antigens will disappear (6, 7) . After leaving GCs, the antigen-selected B cells differentiate into long-lived PCs, which reside in the bone marrow (8, 9) , or become memory B cells. Upon encountering the same antigen, memory B cells predominantly respond and differentiate into PCs. Therefore, affinity-matured and class-switched antibodies are abundant in the secondary immune response. The affinity maturation and repertoire changes of anti-(4-hydroxy-3-nitrophenyl)acetyl (NP) IgG antibodies have been reported (10) (11) (12) . The canonical anti-NP antibodies produced in C57BL/6 mice are composed of heavy chains encoded by the V H 186.2 gene segment and λ light chains (13, 14) , most of which have tyrosine or glycine at position 95 (according to the amino acid residue numbering system of Kabat et al. (15) ) of the heavy chain. Tyr95-type antibodies have tyrosine at this position and are found frequently in the primary response. Gly95(H)-type antibodies, which have glycine at position 95 and histidine at position 100, are found in the secondary response (11, 16) . Tyr95-type antibodies can increase affinity quickly because a single amino acid substitution at position 33 (referred to as the W33L mutation) can raise affinity to NP ~10-fold (17) (18) (19) , with added mutations causing a modest increase in affinity. Gly95(H)-type antibodies require multiple mutations in both heavy and light chains for an increase in affinity (20, 21) . Therefore, affinity maturation progresses slowly, but after accumulating multiple mutations, their affinity reaches ~1000-fold higher than those of germline antibodies. The rapid maturation enables the rise of Tyr95-type antibodies in the early phase of the immune response, while Gly95(H)-type antibodies can overcome competition later by higher evolvability. As described, the affinity maturation of anti-NP IgG antibodies is closely related to generation of memory B cells capable of acquiring higher affinity by SHM through a GC-dependent pathway. The induction of SHM and antibody evolvability determined by the amino acid residue at position 95 are critical factors for establishment of IgG + memory B cells.
Memory B cells were formerly defined as those possessing class-switched and somatically mutated Ig genes since they were thought to be generated only through a GC-dependent pathway. Recently, however, heterogeneity of memory B cells, in terms of BCR isotypes and SHM expression, has been reported (22) (23) (24) and IgM + memory B cells have been shown to exist (25) (26) (27) (28) and to be generated through a GC-independent pathway (29, 30) . Although IgM antibodies are considered to be secreted at the early stage of primary immunization and have lower affinity than IgG antibodies, it is interesting to examine how these IgM + memory B cells are involved in antibody production and to determine whether IgM antibodies of the primary and secondary responses are different from each other in terms of structure and function. In addition, IgM antibodies in the secondary immune response may be different from IgG antibodies since the numbers of mutations possessed by IgM + and IgG + memory B cells were reported to be different (23, 31) .
In this study, we established hybridomas producing anti-NP antibodies and analyzed sequences of Ig genes and their affinities to NP. We report here that the IgM repertoire of the secondary response is more heterogeneous than the IgG repertoire in terms of V H gene usage. There are many unmutated V H genes. V H genes that have codons corresponding neither to tyrosine nor to glycine at position 95 (designated as X95 type) are frequently found. These genes encode antibodies with a very low affinity to NP but grant them a higher capacity to activate the complement pathway. V H genes with these features are frequently found in IgM + PCs in the secondary response. These results suggested that B cells with different types of BCRs are selected as IgM + memory B cells and differentiate into PCs in the secondary immune response.
Methods

Mice and immunization
C57BL/6 mice were purchased from Japan SLC (Shizuoka, Japan). AID-deficient mice (5) were crossed with C57BL/6 mice for more than 10 generations. Mice more than 8 weeks old were used for immunization. NP-CGG (chicken γ-globulin) (Rockland, Gilbertsville, PA, USA) whose NP valence was 30-40 per CGG molecule was prepared as previously described (32) . NP-CGG was precipitated with alum, and 100 μg of antigen was intra-peritoneally injected into mice. The boost immunization consisted of an intra-peritoneal injection of 100 μg of NP-CGG in PBS. The experiments were carried out following the Guidelines for Animal Protocols of Tokyo University of Science or those of Kochi Medical School.
Establishment of hybridomas secreting anti-NP antibodies and sequence analysis of Ig genes
To establish primary-response hybridomas, mice were immunized with NP-CGG/alum, and on day 7 or 14, mice were sacrificed and spleens were taken. For secondary-response hybridomas, mice were challenged with NP-CGG in PBS on day 53, and sacrificed 3 days later (day 56). Singlecell suspensions were prepared and the cells were fused with SP2/0-Ag14 myeloma cells using PEG1500 (Roche Diagnostic, Mannheim, Germany). Selection was started 2 days after cell fusion using culture media containing HT media supplements and aminopterin (Sigma, St Louis, MO, USA). Two weeks later, growing cells were screened for anti-NP antibody production by ELISA in which NP-BSA was coated onto microtiter plates and bound antibodies were detected by peroxidase-conjugated goat anti-mouse IgG or IgM antibodies. IgG subclasses and types of light chains (κ or λ chain) were determined using antibodies specific to these molecules (Southern Biotech, Birmingham, AL, USA). Clones secreting antibodies reacting to NP-BSA but not to BSA were subcloned by limiting dilution. mAbs were purified from culture supernatants on an NP-BSA column as previously described (11) . In some experiments, unpurified culture supernatants were used after antibody concentrations were determined by ELISA.
Total RNA samples were prepared from hybridoma cells with Trizol (Invitrogen, Carlsbad, CA, USA) and cDNAs were synthesized with Reverscript reverse transcriptase (Wako Chemicals, Osaka, Japan) using an oligo dT primer (Invitrogen). IgH genes were amplified by PCR using the sense V H 186.2-specific primer V H -S1, and one of the C regionspecific antisense primers, Cμ-A1, Cγ1-A1 or Cγ2b-A1 (the primer sequences used in this report are summarized in 
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Supplementary Table 1, available at International Immunology Online). IgL genes were amplified using the Vλ-specific primer Vλ-S1 and the Cλ1-specific primer Cλ1-A1 or the Cλ2,3-specific primer Cλ2,3-A1. Amplified fragments were purified by agarose gel electrophoresis and sequences were determined using an ACE2000XLE DNA sequencer (Beckman Coulter, Brea, CA, USA). The primers used for sequencing reactions were Cμ-A2 (Cμ), Cγ1-A2 (Cγ1), Cγ2b-A2 (Cγ2b), Cλ1-A2 (Cλ1) or Cλ2,3-A2 (Cλ2 and Cλ3).
Preparation of control IgM and affinity measurement by ELISA
The genes encoding V H -D and part of J H 2 were amplified from cDNA of the anti-NP IgG1-producing hybridomas, N1G9 (18) and B2 (11) , by PCR using the 5′ V H primer V H -S2 and the J H 2 antisense primer J H 2-A. The gene encoding J H 2 and Cμ was amplified from cDNA prepared from spleen cells of C57BL/6 mice using the J H 2 sense primer J H 2-S and the 3′ Cμ primer Cμ-A3. In order to obtain the hybrid cDNA of the anti-NP V H region fused with the Cμ domain, the amplified products were mixed and reamplified with primers V H -S2 and Cμ-A3. The hybrid cDNA was cloned into the cloning site downstream of the EF-1α promoter in pBudCE4.1 vector (Invitrogen). These constructs were transfected into the J558L myeloma cell line (33) by electroporation as previously described (34) . After selection with Zeocin (Invitrogen), stable transfectant clones were isolated by limiting dilution. IgM in the culture supernatant was then purified on an NP-BSA column.
Anti-NP mAbs were diluted to 1 μg ml −1 in PBS containing 0.1% (v/v) Tween 20. When culture supernatants were used without purification, IgM was diluted with medium. NP-BSA with various NP valences was prepared as described previously (32) . The molecular ratios of NP per BSA are expressed as subscripts. MaxiSorp ELISA plates (Nunc, Roskilde, Denmark) were coated with 50 μl of NP-BSA of varying NP valence (10 μg ml −1 ) in PBS overnight at 4°C. After washing and blocking (3% skimmed milk in PBS), the wells were seeded with 50 μl of the diluted samples and incubated for 1 h at room temperature. After washing, the amount of antibody bound to the plates was detected by reacting with either peroxidase-or alkaline phosphatase-conjugated goat antimouse IgG or anti-mouse IgM antibodies (Southern Biotech). DNA containing exons 1-4 of the Cμ gene was amplified from genomic DNA of C57BL/6 mice by PCR using Cμ-S and Cμ-A3 primers and cloned into pEF1/Myc-HisA vector (Invitrogen). V H genes from PCs were then excised and cloned into the 5′ end of Cμ exons, and the resulting expression vectors were transfected into J558L cells. After selecting with G418 (Wako Chemicals), stable transfectants were cloned by limiting dilutions. Culture supernatants were collected and IgM concentrations were determined by ELISA using goat anti-mouse IgM antibodies.
Preparation of NP-RBC and complement-mediated hemolysis
An NP-RBC suspension was prepared by reacting sheep RBCs (1 × 10 9 cells ml −1
) with 1 mM succinimide ester of NP for 30 min. After the reaction, the cells were washed with isotonic veronal buffer with Ca 2+ , Mg 2+ and gelatin. Culture supernatants of hybridomas at various dilutions in medium were added to NP-RBC suspensions and incubated for 90 min on ice. In order to normalize the amount of IgM mAbs bound to the NP-RBCs, the bound IgM was detected using an FITClabeled goat anti-mouse λ chain antibody (Southern Biotech) and levels were measured by flow cytometry. NP-RBCs to which IgM had bound were washed and reacted with 32-fold diluted rabbit sera for 60 min at 37°C. After the reaction, the remaining cells were centrifuged and the absorbance of the supernatant was measured at 415 nm. After subtracting the amount of non-specific hemolysis, specific hemolysis was calculated as the percentage of total hemolysis in distilled water.
Results
The IgM mAb repertoire was different from the IgG repertoire in the secondary immune response
We prepared hybridomas by fusing splenocytes of NP-CGGimmunized mice with myeloma cells, and screened anti-NP mAb production by ELISA. Numbers of anti-NP mAb-producing clones are shown in Table 1 . We obtained 30 and 10 clones on days 7 and 14 after primary immunization of C57/BL6 mice, respectively. Three clones produced mAbs bearing κ light chains, while the others secreted mAbs with λ light chains. The nucleotide sequences of V-region genes of λ-bearing mAbs were determined after amplification by RT-PCR. It was found that the heavy chains of 24 mAbs were encoded by the canonical V H 186.2 gene and those of six mAbs by V H 186.2-related genes. The cDNA of other mAbs could not be amplified by the primers, and they are considered to be encoded by genes unrelated to the V H 186.2 gene. Among V H 186.2/λ-producing clones, 7 produced IgM and 17 produced IgG. In order to analyze the effect of SHM and CSR on the antibody repertoire, hybridomas were also prepared from immunized AID-deficient mice at the same time points. Nineteen anti-NP IgM-producing clones were isolated on day 7 and five on day 14. By sequence analysis, we found eight clones bearing V H 186.2 heavy chains and λ light chains. The preferential usage of these genes was consistent with previous studies (13, 14) and was not affected by AID deficiency. In order to compare the antibidy repertoire between the primary and secondary immune response, we prepared hybridomas from boost-immunized mice. Splenocytes were taken 3 days after boost immunization with NP-CGG in PBS. At this time point, anti-NP antibodies in sera were clearly detected by ELISA using NP 23 and Vλ genes, we focused our further attention solely on these mAbs.
The structural properties of the mAbs encoded by V H 186.2 and Vλ genes are shown in Tables 2 and 3 . Amino acid sequences of V regions are shown in Supplementary Figures 2 and 3, available at International Immunology Online. Anti-NP mAbs were classified into four types according to the amino acid residues that are critical for affinity maturation of anti-NP IgG antibodies. Many antibodies established in this study belonged to the three types (Tyr95, Tyr95W33L and Gly95(H) types) that have already been described (20, 21) . However, some mAbs did not have tyrosine or glycine at position 95 of the V H gene and were sorted as the X95 type ( Fig. 1 ). All IgM mAbs and 15 of 17 IgG mAbs collected from C57BL/6 mice on days 7 and 14 had tyrosine at position 95. Clone 1B6 was considered an X95 type because it had glycine at position 95 but not histidine at position 100. It was concluded that the anti-NP mAbs predominantly consisted of the Tyr95 and Tyr95W33L types (92%) irrespective of the heavy chain isotype in the primary antibody repertoire. The structural properties of day 7 and day 14 mAbs of AID-deficient mice were essentially the same as those of C57BL/6 mice except that the former generated IgM mAbs only. Six out of eight IgM mAbs were of the Tyr95 type and the other two had either glycine or arginine at position 95. Because SHM does not occur in AID-deficient mice, the variation in the amino acid at position 95 was not a result of SHM.
Although the frequency was low, we found mutations in day 7 IgM mAbs. 1B366 showed three amino acid replacements in V H . Another IgM mAb, 1B269, also had a replacement in Vλ1. In contrast, no amino acid replacement was observed in V genes of day 7 IgG mAbs, which was in agreement with previous observations (10, 14, 35, 36) . The day 14 IgG mAbs had tyrosine at position 95. All had acquired amino acid replacements by SHM. Two IgG clones and one IgM clone were of the Tyr95 type with a W33L mutation, suggesting that affinity-based selection in the GC has occurred by this time point. As expected, no SHM was observed in hybridomas obtained from AID-deficient mice.
The secondary-response IgG mAbs from C57BL/6 mice were characterized by the frequent appearance of the Gly95(H) type (4 out of 7, 57%). This type of mAb showed multiple replacements of amino acids in both V H and Vλ regions, which were caused by SHM, and all had a lysine to arginine mutation in the heavy chain at position 58 (16) . Similarly, Tyr95-type mAbs also showed a number of amino acid replacements, including the W33L mutation, although one Tyr95 mAb, 8B550, harbored no mutations at all. Therefore, as described previously (11), the preferential appearance of the heavily mutated Gly95(H) type was characteristic of the IgG produced in the secondary immune response. In contrast, IgM mAbs from boost-immunized mice lacked amino acid replacements caused by SHM. We detected X95-type mAbs, which were rarely found in the primary repertoire or in IgG mAbs of the secondary response. These results suggested that, in C57BL/6 mice, B-cell populations activated for the production of IgG and IgM in the secondary immune response are different. Four out of nine clones from AIDdeficient mice had glycine at position 95, but they did not have histidine at position 100 in CDR3 and should be categorized as the X95 type. This suggested that the frequent appearance of Gly95(H)-type antibodies in the secondary response depended on CSR and SHM. As in the C57BL/6 mice, different populations of B cells were involved in the primary and secondary immune responses of the AID-deficient mice, although all mAbs were IgM and had not undergone SHM. 
Dynamics of anti-NP IgM antibody production 199
Binding on ELISA of very low-affinity IgM to NP depended on epitope valences
In order to clarify whether the change in the repertoire of IgMs during the immune response to NP depended on affinitybased selection, we measured the relative affinities of these mAbs. We prepared recombinant IgM of known affinity using V H -D-J H genes from two IgG1 mAbs and verified the methods for comparing the affinities of IgM mAbs. N1G9 is a primary germline Tyr95-type IgG1, while B2 is an affinity-matured IgG1 with the W33L mutation. , respectively (11, 18) . The V H -D-J H genes were amplified and joined to the Cμ gene by PCR and expressed in J558L cells that produce germline λ1 light chains without heavy chains (33) . The recombinant IgMs with N1G9 or B2 V H region genes were termed N1G9-IgM and B2-IgM, respectively. We first measured the interaction between NP-ε-aminocaproic acid and the recombinant antibodies, as well as between other mAbs, using isothermal titration calorimetry (11, 12) . However, the measurement of IgM mAbs from NP-CGG-immunized mice was not possible because their affinities were too low to be determined by this method, although levels of recombinant N1G9-IgM and B2-IgM were determined (data not shown). Therefore, we analyzed affinity by ELISA. Calculation of ratios of antibody binding to NP-BSA with different NP valences using ELISA has been widely used as a conventional method for estimating the affinity of IgG antibodies (37, 38) . We examined 
a D H genes of some clones could not be identified and are indicated as x. SP2 represents a D SP2 family member. In the case of IgG mAbs, N1G9 had a binding ratio close to zero, while that of B2 was 0.6 ( Fig. 2A) . This result indicated that B2 has a relatively higher affinity than N1G9, as expected. In contrast to IgG, N1G9-IgM and B2-IgM had a ratio of ~1, suggesting that an IgM with an affinity higher than that of N1G9-IgM would provide the same ratio due to its high avidity involving 10 antigen-binding sites of IgM (39) . Because our IgM mAbs showed lower affinity than that of N1G9-IgM in isothermal titration calorimetry experiments, we searched for experimental conditions for comparing the relative affinities of these IgM mAbs. We chose five IgM antibodies including N1G9-IgM and compared profiles of the binding of NP-BSA of different NP valences (Fig. 2B ). N1G9-IgM bound to NP-BSA with little dependence on the NP valence. 1A236, 1A8 and 8A507 bound NP 1 -and NP 2 -BSA less efficiently, although they were able to bind to antigen with an NP valency of more than 6. 1A32, which is an anti-NP IgM with κ light chains, showed inefficient binding to NP 8 -BSA. All IgM mAbs bound to NP 26 -BSA to the same degree. These results suggested that binding to NP 2 -BSA (NP Lo ) depended on affinity, while binding to NP-BSA with an NP valence of more than 20 (NP Hi ) was independent of affinity. Next, we examined the effect of the IgM concentration. The amount of N1G9-IgM that bound to NP 2 -BSA rose with increasing concentrations, but that of Amino acid residues at position 33. 
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1A32 remained marginal, even at 10 μg ml −1 (Fig. 2C) . On the other hand, in binding to NP 26 -BSA, little difference was observed among IgM mAbs (Fig. 2D) . Therefore, the relative affinity of IgM could be compared using the NP Lo /NP Hi binding ratio at an antibody concentration of 1 μg ml −1 , when the IgM mAb in question has an affinity lower than that of N1G9-IgM.
Very low-affinity anti-NP IgM antibodies were frequently found in secondary responses
The day 7 IgG mAbs from C57BL/6 mice had a ratio of 0-0.3 (Fig. 3A ). An increase in the binding ratio was observed in a day 14 IgG mAb with the W33L mutation. With two exceptions, most mAbs obtained from boost-immunized mice showed higher ratios (> 0.7) than day 7 IgG mAbs, suggesting that affinity-matured IgG antibodies were selected during the immune response.
Next, we analyzed the relative affinities of IgM mAbs by ELISA. We tentatively classified IgM mAbs on the basis of their NP Lo /NP Hi binding ratios. IgM mAbs with a ratio lower than 0.2 were termed NP Lo − , while other mAbs with a ratio higher than 0.2 were termed NP Lo + . Their affinities were relatively high, but perhaps not higher than that of N1G9-IgM. Primary-response IgM mAbs of both C57BL/6 (Fig. 3B) and AID-deficient mice (Fig. 3C) belonged to the NP Lo + group except for 1A376, with arginine at position 95, which had a ratio of 0.03. Therefore, the frequency of NP Lo + IgMs among these IgM mAbs was 12/13 (92%). On the other hand, NP Lo − IgM mAbs were abundant among IgMs from boost-immunized C57BL/6 mice, comprising 50% of the total. These results suggest that, in contrast to IgG mAbs, the relative affinities of IgM mAbs do not increase but actually decrease during the immune response in C57BL/6 mice. Two X95-type IgMs were found in day 56 mAbs and both were NP Lo − . The frequency of NP Lo − IgM mAbs of AID-deficient mice was 4/7 (57%). In spite of glycine at position 95, 8A38 and 8A303 were NP Lo − , while the affinity of the Gly95(H) type without mutation (1A350) was the same as that of the Tyr95 type, as described previously (21) . Therefore, they are considered to be the X95 type. NP Lo + IgM mAbs were abundant among Tyr95-type IgMs, while X95 types tended to be NP Lo − in the absence of SHM. However, since some Tyr95-type mAbs (8B668, 8A507 and 8A307) were NP Lo − , structural differences between NP Lo + and NP Lo − IgM may not be explained simply by the amino acid residue at position 95.
Unmutated and X95-type V H genes were frequently found in secondary-response IgM + PCs
The frequent appearance of the X95-type and very low-affinity IgM mAbs in the secondary response was unexpected. Therefore, we examined whether such IgM antibodies are produced in vivo. ELISA showed that the relative affinities From the repertoire of day 5 after boost immunization, we also found the Gly95(H) type with multiple mutations. The appearance of affinity-matured sequences was similar to findings in the repertoire of IgG-producing hybridomas. When we analyzed the V H repertoire of IgM + Igλ + PCs on day 3 after boost immunization, which was the same time point as when hybridomas were prepared, we found that most of the sequences did not contain amino acid replacements and 32% (6 out of 19) were of the X95 type. In the V H repertoire of IgM + Igλ + PCs on day 5 after boost immunization, we found more clones with mutations including the W33L mutation. This suggested that unmutated X95-type IgM antibodies and affinity-matured IgM antibodies are produced in the secondary response.
Because we did not analyze sequences from single cells, we could not gain sequence information on pairing light chains. Amino acid replacements in light chains contribute to affinity maturation (20) , so that we could not speculate on the affinities of mutated V H genes from PCs. We chose V H genes without mutations, assuming that their partner light chains were in germline configuration. V H genes were recloned into the expression vector containing Cμ exons and transfected into J558L cells. Culture supernatants containing recombinant IgM were subjected to ELISA. Nine out of ten (90%) recombinant Tyr95-type IgMs from primary immunization were NP Lo + (Fig. 5A ). On the other hand, 7 out of 14 (50%) of the IgMs constructed with sequences of the secondary immune response were NP Lo − (Fig. 5B) . X95-type IgMs showed lower affinity, and two of them were NP Lo + but the ratios were relatively low. Therefore, we concluded that unmutated very lowaffinity IgM antibodies, which were found in hybridomas, were produced in vivo in the secondary immune response.
Low-affinity IgM mAbs showed higher complementdependent hemolysis activity
It was rather surprising that, in contrast to affinity maturation of IgG, very low-affinity IgM antibodies are produced in the secondary immune response. In order to address the question of whether such very low-affinity IgM antibodies have any role in biological defense, we analyzed the relationship between affinity and antibody function. Because one of the most important functions of IgM is to activate the classical pathway of the complement cascade, we compared hemolytic activity toward NP-RBCs using rabbit sera as the source of complement factors. Flow cytometry analysis showed that all of IgM mAbs bound to NP-RBCs when the NP valence on the surface was sufficiently high. Because the amount of bound IgM on RBCs is a critical factor in initiating hemolysis, it was analyzed by flow cytometry and the concentration of each IgM mAb was adjusted to give similar geometric means of fluorescence intensity (Fig. 6A) . Interestingly, IgM mAbs having higher affinity activated hemolysis less efficiently than mAbs with lower affinity (Fig. 6B) . It is evident that hemolytic activity was inversely correlated with the NP Lo /NP Hi binding ratio, i.e. affinity (Fig. 6C) . This cannot be explained by the lack of complement activation by IgM mAbs with higher affinity since when NP-RBCs with a low number of NPs were used, hemolysis was effectively induced (Supplementary Figure 5 , available at International Immunology Online). These results suggested that low-affinity IgM antibodies secreted during the secondary response were superior to higher affinity IgM antibodies in their ability to activate complement when the epitope density was high.
Discussion
Class-switched memory B cells are important for affinity maturation and the repertoire shift of IgG antibodies in the secondary immune response. Recent studies of B-cell memory revealed the presence of IgM + or unmutated memory B cells. Antigen-dependent selection in GCs establishes affinity-matured memory B cells, while memory B cells can also be derived via a GC-independent pathway (30) . Although some IgM + memory B cells have mutated V H genes, a significant portion of IgM + memory B cells are unmutated (40) . It is reported that memory B cells can be generated even by T cell-independent antigens (41). Marginal-zone B cells (42) or B1b cells (43) contribute to IgM + memory. We have analyzed cDNA sequences of NP-binding memory B cells and found not only affinitymatured but also unmutated low-affinity IgM + memory B cells (submitted). However, it was not clear whether these IgM + memory B cells contribute to IgM antibody production in the secondary immune response. 
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In order to compare antibody repertoires during the immune response, we determined sequences of Ig genes of hybridomas and PCs at different time points after immunization. Since both sequence analysis and functional analysis are important for elucidating the biological significance of antibodies, we analyzed affinities and complement activation capacities. On day 7 after immunization, most IgG hybridomas secreted Tyr95-type mAbs. The absence of mutations in their V H region suggests that they developed directly from naive B cells without GC involvement. Similarly, most of the V H genes of class-switched PCs were of the Tyr95 type without mutation, indicating that the hybridoma repertoire represented the repertoire of antibodies produced in vivo. Since two of the IgG mAbs prepared from mice on day 14 after immunization were of the Tyr95W33L type and showed increased affinity to NP, the GC reaction and affinity-based selection had already occurred at this time point. In IgG mAbs prepared from boost-immunized mice, we found an increased frequency of affinity-matured types, i.e. Tyr95W33L and Gly95(H) mAbs with multiple mutations. They presumably originated from GC-dependent memory B cells. As expected, ELISA showed that most of them had increased affinity to NP. There were two exceptional IgG mAbs with low affinity. 8B529 had the W33L mutation but also had additional mutations that decreased affinity, as described previously (21) . 8B550 had the germline sequence, so that it may have originated from a GC-independent memory B cell. V H sequences of classswitched PCs frequently contained the Tyr95W33L type, and the Gly95(H) type appeared on day 5 after boost immunization. Therefore, the affinity-matured IgG antibodies that were found in the hybridoma repertoire were produced in vivo. In contrast to the hybridoma repertoire, the class-switched PC repertoire contained more of the Tyr95 type without the W33L mutation. We could not measure the affinities of these mutated antibodies because paired light chains were not identified.
Similar to the IgG repertoire, most IgM mAbs of the primary response on day 7 were of the Tyr95 type without mutations, and all of the V H genes isolated from IgM + PCs were also of the Tyr95 type without mutations. These results suggested that, at this time point, almost the same populations of naive B cells are selected to differentiate into IgM PCs and IgG PCs without passing through GCs. The fact that IgM mAbs harbored mutations suggested that these cells had undergone SHM without CSR in GCs. The IgM repertoire of boostimmunized mice was different. We found not only Tyr95-type but also X95-type IgM mAbs, and all of them were in the germline configuration. Most IgM mAbs of the Tyr95 type had a higher NP Lo /NP Hi binding ratio (NP Lo + ) even without mutations, while X95-type IgM mAbs had very low-affinity (NP Lo − ). V H genes of PCs from mice 3 days after boost immunization contained many unmutated genes including the X95 type. On generating recombinant antibodies with V H genes from PCs, we confirmed that these antibodies bind NP with relatively lower affinity than Tyr95-type V H genes of the primary PC repertoire. One possible explanation for why the X95 type was not found in the IgG hybridoma repertoire is that its affinity was too low to be detected by ELISA in the form of IgG. The formation of the IgM pentamer increases avidity so that it was able to be detected by hybridoma screening. However, PCs were sorted as Igλ + cells and the repertoire was not biased by the NP-binding capacity. Since memory B cells can respond more rapidly and vigorously than naive B cells, most secondary-response antibodies can be considered to be derived from memory B cells. It is still possible that naive B cells can be stimulated with help from memory T h cells to produce IgM after secondary immunization, as shown in rat chimeras (44) . However, when mice were immunized with CGG to induce T h cells and boost immunized with NP-CGG, we found a slight increase in anti-NP IgM production (Supplementary Figure 6, (27, 30, 50) . Our results suggested that they do differentiate into IgM + PCs, although we did not determine the relative incidence of these two IgM + memory B-cell fates.
The V H repertoire of IgM + PCs on day 3 after boost immunization contained mainly unmutated genes, while the day 5 repertoire had many sequences with mutations, which included those with mutations such as W33L, which result in higher affinity. These results suggest that IgM + memory B cells without mutations respond to boost immunization more quickly than do mutated memory B cells. This may be because of the difference between GC-independent and GC-dependent IgM + memory B cells, with the former being more susceptible to activation than the latter. Alternatively, B cells with low-affinity BCRs may be activated more efficiently in the presence of memory T h cells. It was shown that antigens that are bound to lower affinity BCRs are more efficiently presented on class II MHC molecules (51) and that these cells may receive more help from T cells. In addition, after boost immunization, highaffinity IgG antibodies are produced in vivo, which may inhibit B-cell activation especially that of cells with low-affinity BCRs (31) on day 5 after immunization. These possibilities need to be elucidated by further experiments.
We showed dynamic changes in antibody production following immunization with NP-CGG. A boost immunization induced the production of IgM antibodies, in addition to the affinity-maturated IgG antibodies, which play an important neutralizing role. The high avidity of IgM antibodies is known to be due to their harboring of 10 antigen-combining sites per molecule. In this study, we used NP-CGG with a relatively high density of hapten so that IgM could bind antigens efficiently even if their affinity was low. This type of polyvalent structure is widely observed in the lectin family and is considered to be useful for recognizing repeated molecular patterns on bacteria or viruses (52) . IgM antibodies are known to have a strong capacity for aggregation and to efficiently activate the classical complement pathway. Because of these functional advantages, IgM antibodies are able to play an important protective role in influenza virus infection (53, 54) . IgM produced from B1b cells can eliminate a Borrelia hermsii infection and confer T cell-independent long-lasting immunity (43) . Before affinity-matured IgG antibodies have made their appearance, primary IgM antibodies provide the only antibody defense against invasion by microorganisms. However, even after matured IgG antibodies appear, IgM antibodies would likely have a continuing role in secondary immunization. The production of low-affinity IgM in the secondary response was observed in transgenic mice (46) , although its biological significance was unclear. In the present study, we showed that IgM mAbs with very lower affinity were superior to those with higher affinity in a hemolytic assay using NP-RBC. Moreover ) bind C1 less efficiently than IgG does. IgM consists of five subunits, each of which has two antigen-binding sites. Without antigen binding, this large structure has a planar conformation, which does not induce activation of the complement cascade because C1 can bind to it with low affinity. The interaction with antigen can induce conformational changes, which depend on many factors such as affinity, epitope density and the flexibility of IgM pentamer. The formation of a staple-like structure enables C1 to bind to IgM efficiently (57, 58) . When a high-affinity IgM pentamer binds to a high-epitope-density ligand such as NP-RBC (Fig. 6) , it is assumed that the interaction of one or two antigen-binding sites of one IgM subunit is sufficient for binding. Therefore, there is no need to change the conformation so that the IgM pentamer binds to NP-RBC in the planar form. If the same IgM binds to antigen when the span of each epitope is too long for two antigen-binding sites of one IgM subunit to bind simultaneously, other subunit(s) in the pentamer will be involved in antigen binding and the IgM will assume a staple-like conformation, which enhances C1 binding and complement activation. On the other hand, lowaffinity IgM cannot bind to NP-RBCs with one IgM subunit and participation of the other subunits of the IgM pentamer is required for sufficient binding. When several antigen-binding sites are occupied, the IgM conformation will assume a staplelike form. Therefore, during interactions with NP-RBCs of high NP density, high-affinity and low-affinity IgM could preferentially form planar and staple-like conformations, respectively. Although further study is required to verify this hypothesis, our results suggest that very low-affinity IgM antibodies have unique immunological functions. IgM likely competes with IgG in binding to epitopes on pathogens through the high avidity provided by its ten antigen-combining sites. Since an increase in binding by multiple interactions is more pronounced when antibody-combining sites have a lower intrinsic affinity (32) , it is speculated that IgM with very low affinity can recognize pathogens with multiple epitopes through its high avidity, even during secondary immunization with T celldependent antigens.
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